Home Page
News Lines
Classifieds
Real Estate MLS
Profiles
Arcade
Business Directory
Hotels
Advertise
Long Island New York
Google Web Site
 
 

PHARMACEUTICAL NEWS LINES

Advertisement



Halozyme takes bigger loss on testing expenses (AP) AP - Biotechnology company Halozyme Therapeutics Inc. reported a bigger third-quarter loss on Friday, as it started clinical trials of a fast-acting insulin during the period.




Threshold Pharmaceuticals 3Q loss widens on costs (AP) AP - Threshold Pharmaceuticals Inc., a development-stage biotechnology company, said late Thursday its third-quarter loss widened on higher research, development, and interest expenses.


Mass. man faces new charges in alleged terror plot (AP)

In this Feb. 11, 2009  image rendered from video and provided by WHDH-TV in Boston, Tarek Mehanna is seen outside the federal court in Boston. Federal authorities in Boston said Wednesday, Oct. 21, 2009, that Mehanna has been charged  with conspiring with others on terror attacks against shoppers in U.S. malls and against U.S. military in Iraq. (AP Photo/WHDH-TV)AP - A pharmacy college graduate was indicted Thursday on new charges in an alleged terror plot to kill two prominent U.S. politicians and shoot people at American shopping malls.





On the Call: Cigna President David Cordani (AP) AP - Health insurer WellPoint Inc. announced plans last spring to sell its pharmacy benefits management business to Express Scripts Inc. for about $4.68 billion. Analysts have wondered whether other managed care companies would consider a similar sale.


CVS Caremark 3Q profit up but loses big contracts (AP)

In this Nov. 3, 2009 photo, a CVS pharmacy sign is seen opposite the interior of one of the CVS locations, in Providence, R.I. CVS Caremark Corp. said Thursday, Nov. 5, 2009, its third-quarter profit jumped 39 percent on a boost from pharmacy benefits services and drugstore sales. (AP Photo/Steven Senne)AP - CVS Caremark disclosed more multibillion dollar contract losses in its pharmacy benefits management business and said the head of the unit will depart.





King 3Q profit falls on charges, but tops forecast (AP) AP - Drug developer King Pharmaceuticals said Thursday its third-quarter profit was cut in half by charges for related to its $1.6 billion buyout of rival Alpharma Inc.


BioCryst receives $22.5 million peramivir order (AP) AP - BioCryst Pharmaceuticals Inc. said Thursday it will receive $22.5 million as part of a new contract with the Department of Health and Human Services over the intravenous flu treatment peramivir.


Acne, wrinkle treatments help Medicis post profit (AP) AP - Medicis Pharmaceutical Corp. posted a third-quarter profit on Wednesday, as sales of its skin products surged, and a research and development charge came off the books.


BioCryst partner seeks peramivir approval in Japan (AP) AP - BioCryst Pharmaceuticals Inc. said Wednesday its partner Shionogi & Co. filed for approval to market BioCryst's IV flu drug peramivir in Japan.


Affymax 3Q loss narrows partnership payments (AP) AP - Biotechnology company Affymax Inc. said Wednesday its third-quarter loss narrowed on a boost in payments from its partner Takeda Pharmaceutical on the anemia drug candidate Hematide.


You can save this news page by submitting it to your favorite sites: Social Bookmark News

All News Lines - Local and World Wide, Updated Hourly

RSS news lines are HTML instructions and not actual copy. They are displayed here through the doctrine of fair use in the U.S. Copyright Act which allows us to show snippets and links to news and other materials. The fair use doctrine protects limited uses of content, such as indexing to make it easier to find. This allows us to send visitors to breaking news web sites. If your news appears here against your wishes please contact us for removal, disable your RSS feeds or implement simple technical standards such as robots.txt or metatags to prevent search engines (Yahoo and MSN) from feeding us your snippets and links.

 

 
   By using this site you agree to our Terms of Service and Privacy Policy. If you do not agree, please exit the service.
   Copyright © 2002 - 2009 Long Island Exchange ®. All rights reserved. Internet Marketing by Searchen Networks ® Inc.